+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunofluorescence Assay Market Size, Share & Trends Analysis Report By Product (Antibodies, Kits & Reagents, Instruments, Consumables & Accessories), By Type, By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • March 2023
  • Region: Global
  • Grand View Research
  • ID: 5767781
The global immunofluorescence assay market size is anticipated to reach USD 4.95 billion by 2030. The market is expected to reach at a CAGR of 5.29% from 2023 to 2030. Immunofluorescence is a traditional technique used for getting insight into cellular processes and structures using microscopy. For instance, specific proteins can be assessed for their location and expression. Increasing prevalence of chronic and infectious diseases, significant applications of immunofluorescence assay (IFA) in several areas and technological advancements in techniques and associated instruments are key factors driving the market growth.

The immunofluorescence assay market is anticipated to witness rapid growth, owing to the technological advances and launch of novel instruments. For instance, in November 2020, CTK Biotech, Inc. introduced RaFIA immunofluorescence immunoassay system to meet the rising demand for quantitative rapid tests. The system is user friendly, offers a high level of sensitivity and a broad working range. In addition, in March 2021, Euroimmum introduced an automated immunofluorescence microscope EPML (EUROPattern Microscope Live). The instrument comprises of 20x high camera resolution and captures the image within 2 seconds. Such developments are increasing the efficiency and adoption of the technique, thereby fueling the market growth.

The chronic diseases such as Alzheimer’s, HIV, and Chron’s disease have increased globally over the last few decades. For instance, according to CDC, in 2020, 5.8 million individuals in America were living with Alzheimer’s disease. According to WHO, 38.4 million individuals were living with HIV globally by the end of 2021. Hence, the growing awareness and increasing demand for the detection and cure of several chronic and infectious diseases are some of the driving factors for the market growth.

Additionally, the COVID-19 pandemic has boosted the adoption of immunofluorescence assays due to a sharp rise in the demand for rapid, point-of-care testing of the disease. As immonofluroscence assays represent a quick and easy-to-use testing solution for mitigation of COVID-19 outbreak, these assays are expected to witness significant demand for disease surveillance in the near future. Furthermore, international organizations, such as WHO and European Commission, as well as governments around the world have focused on mass population testing, followed by emergency use authorization, for curbing the spread of COVID-19. For instance, For instance, in January 2021, LumiraDx received multinational approval for its SARS-CoV-2 Antigen Test. The immunofluorescence assay is designed for quick and accurate detection of the SARS-CoV-2 antigen in nasopharyngeal or nasal swab specimens. Immunofluorescence assay have enabled frequent testing and decentralization of healthcare for supporting large-scale testing efforts wi
thout the need for complex & extensive infrastructure.

Immunofluorescence assay is being used increasingly in various areas. The major applications of the technique are determination of protein subcellular localization, detection of cell membrane antigens, detection of drugs, detection of humoral antibodies, detection of cell signaling, detection of immunoglobulins, detection of pathogens, visualization of cell structures, and diagnosis of diseases. Such broad range of applications are anticipated to accelerate the market growth in the forecast period.

On the other hand, in IFA, the fluorescently linked antibodies in the sample are detected using advanced imaging technology. Hence, the instruments are expensive and may retrain the market to a certain extend during the projected timeframe. Furthermore, photobleaching, or the destruction of the fluorochrome might hamper the growth of the market in the forecast period. While performing the test or experiment the fluorochrome might lose the color or even degradation in part or whole sample might lead to restart the experiment. Thus, challenges associated with immunofluorescence assay may impede the market. However, key players are striving to develop novel technologies to overcome the limitations associated with the technique.

Immunofluorescence Assay Market Report Highlights

  • Antibodies segment held the largest share of 2022. The immunofluorescence technique relies on the specific antibodies to label a specific target antigen by using fluorescent dyes. For instance, the direct immunofluorescence utilizes an antibody that is conjugated to a fluorescent dye
  • By type, the indirect immunofluorescence assay segment accounted for the largest share in 2022. This can be attributed to the advantages of indirect immunofluorescence such as tends to be less expensive, immunofluorescence, better amplification of the signal, flexibility, and provides a top-notch image
  • By application infectious disease segment dominated the market in 2022 owing to the increasing cases of infectious disease, growing government funding coupled with increased product launches
  • Pharmaceutical and biopharmaceutical companies’ end-user segment dominated the market in 2022 due strategic initiatives, such as mergers & acquisitions, product development, product approvals & launches, and expansion of global operations
  • North America held the largest share of in 2022, presence of key players, existence sophisticated healthcare infrastructure, increase in product approvals, and strong government initiatives & awareness programs to curb the spread of several diseases such as HIV/AIDS, among other factors are driving growth in this region
  • Key market players include Thermo Fisher Scientific Inc., Inova Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abcam plc, PerkinElmer Inc., Merck KGaA, Cell Signaling Technology, Inc., Medipan GmbH, Sino Biological, Inc., Danaher Corporation


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Prevalence Of Chronic And Infectious Diseases
3.2.1.2 Technological Advancements In Immunofluorescence Assays
3.2.1.3 Significant Applications Of Immunofluorescence Assays In Several Areas
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Instruments
3.2.3 Market Challenge Analysis
3.2.3.1 Photobleaching, Or The Destruction Of The Fluorochrome
3.3 Penetration &Growth Prospect Mapping
3.4 Immunofluorescence Assay Market - Porter’s Analysis
3.5 Immunofluorescence Assay Market - Swot Analysis
3.6 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1 Immunofluorescence Assay Market - Product Movement Analysis
4.2 Antibodies
4.2.1 Global Antibodies Market, 2018 - 2030 (USD Million)
4.3 Kits And Reagents
4.3.1 Global Kits And Reagents Market, 2018 - 2030 (USD Million)
4.4 Instruments
4.4.1 Global Instruments Market, 2018 - 2030 (USD Million)
4.5 Consumables And Accessories
4.5.1 Global Consumables And Accessories Market, 2018 - 2030 (USD Million)
Chapter 5 Type Business Analysis
5.1 Immunofluorescence Assay Market - Type Movement Analysis
5.2 Indirect Immunofluorescence
5.2.1 Global Indirect Immunofluorescence Market, 2018 - 2030 (USD Million)
5.3 Direct Immunofluorescence
5.3.1 Global Direct Immunofluorescence Market, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Immunofluorescence Assay Market - Application Movement Analysis
6.2 Cancer
6.2.1 Global Cancer Market, 2018 - 2030 (USD Million)
6.3 Infectious Diseases
6.3.1 Global Infectious Diseases Market, 2018 - 2030 (USD Million)
6.4 Autoimmune Diseases
6.4.1 Global Autoimmune Diseases Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Other Applications Market, 2018 - 2030 (USD Million)
Chapter 7 End-User Business Analysis
7.1 Immunofluorescence Assay Market - End User Movement Analysis
7.2 Academic Research Institutes
7.2.1 Global Academic Research Institutes Market, 2018 - 2030 (USD Million)
7.3 Pharmaceutical & Biopharmaceutical Companies
7.3.1 Global Pharmaceutical & Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
7.4 Cros
7.4.1 Global Cros Market, 2018 - 2030 (USD Million)
7.5 Hospital And Diagnostic Centers
7.5.1 Global Hospital And Diagnostic Centers Market, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis
8.1 Immunofluorescence Assay Market: Regional Movement Analysis
8.2 North America
8.2.1 Swot Analysis
8.2.1.1 North America Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 U.S. Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Canada Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Swot Analysis
8.3.1.1 Europe Immunofluorescence Assay Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Key country dynamics
8.3.2.2 Competitive scenario
8.3.2.3 Germany Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.3 France
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 France Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.4 U.K.
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 U.K. Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Italy Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Spain Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Denmark Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Sweden Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Norway Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Swot Analysis
8.4.1.1 Asia Pacific Vacuum Blood Collection Tube, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive scenario
8.4.2.3 Japan Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 China Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 India Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Australia Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 South Korea Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Thailand Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Swot Analysis
8.5.1.1 Latin America Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Brazil Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Mexico Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Argentina Immunofluorescence Assay Market, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (Mea)
8.6.1 Swot Analysis
8.6.1.1 Mea Immunofluorescence Assay Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 South Africa Immunofluorescence Assay Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Saudi Arabia Immunofluorescence Assay Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 Uae
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Uae Immunofluorescence Assay Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key country dynamics
8.6.5.2 Competitive scenario
8.6.5.3 Kuwait immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD million)
Chapter 9 Competitive Landscape
9.1 Participant’s Overview
9.2 Financial Performance
9.3 Participant Categorization
9.3.1 Market Leaders
9.3.1.1 Immunofluorescence Assay Market Share Analysis, 2022
9.3.1.2 Company Profiles
9.3.1.2.1 Thermo Fisher Scientific Inc.
9.3.1.2.2 Inova Diagnostics, Inc.
9.3.1.2.3 Bio-Rad Laboratories, Inc.
9.3.1.2.4 Abcam Plc
9.3.1.2.5 Perkinelmer Inc.
9.3.1.2.6 Merck Kgaa
9.3.1.2.7 Cell Signaling Technology, Inc.
9.3.1.2.8 Medipan Gmbh
9.3.1.2.9 Sino Biological, Inc.
9.3.1.2.10 Danaher Corporation
9.3.2 Strategy Mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 4 Global immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 5 Global immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 6 Global immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 7 Global immunofluorescence assay market, by region, 2018 - 2030 (USD Million)
Table 8 North America immunofluorescence assay market, by country, 2018 - 2030 (USD Million)
Table 9 North America immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 10 North America immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 11 North America immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 12 North America immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 13 U.S. immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 14 U.S. immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 15 U.S. immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 17 Canada immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 18 Canada immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 19 Canada immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 20 Canada immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 21 Europe immunofluorescence assay market, by country, 2018 - 2030 (USD Million)
Table 22 Europe immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 23 Europe immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 24 Europe immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 25 Europe immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 26 Germany immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 27 Germany immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 28 Germany immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 29 Germany immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 30 U.K. immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 31 U.K. immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 32 U.K. immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 33 U.K. immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 34 France immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 35 France immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 36 France immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 37 France immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 38 Italy immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 39 Italy immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 40 Italy immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 41 Italy immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 42 Spain immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 43 Spain immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 44 Spain immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 45 Spain immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 46 Denmark immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 47 Denmark immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 48 Denmark immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 49 Denmark immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 50 Sweden immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 51 Sweden immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 52 Sweden immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 53 Sweden immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 54 Norway immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 55 Norway immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 56 Norway immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 57 Norway immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 58 Asia Pacific immunofluorescence assay market, by country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 60 Asia Pacific immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 63 China immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 64 China immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 65 China immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 66 China immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 67 Japan immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 68 Japan immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 69 Japan immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 70 Japan immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 71 India immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 72 India immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 73 India immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 74 India immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 75 South Korea immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 76 South Korea immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 77 South Korea immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 78 South Korea immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 79 Australia immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 80 Australia immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 81 Australia immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 82 Australia immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 83 Thailand immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 84 Thailand immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 85 Thailand immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 86 Thailand immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 87 Latin America immunofluorescence assay market, by country, 2018 - 2030 (USD Million)
Table 88 Latin America immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 89 Latin America immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 90 Latin America immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 91 Latin America immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 92 Brazil immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 93 Brazil immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 94 Brazil immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 95 Brazil immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 96 Mexico immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 97 Mexico immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 98 Mexico immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 99 Mexico immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 100 Argentina immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 102 Argentina immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 103 Argentina immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa immunofluorescence assay market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 109 South Africa immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 111 South Africa immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 112 South Africa immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 117 UAE immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 118 UAE immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 119 UAE immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 120 UAE immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 121 Kuwait immunofluorescence assay market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait immunofluorescence assay market, by type, 2018 - 2030 (USD Million)
Table 123 Kuwait immunofluorescence assay market, by application, 2018 - 2030 (USD Million)
Table 124 Kuwait immunofluorescence assay market, by end - user, 2018 - 2030 (USD Million)
Table 125 Participant’s overview
Table 126 Financial performance
Table 127 Key companies undergoing expansions
Table 128 Key companies undergoing acquisitions
Table 129 Key companies undergoing collaborations
Table 130 Key companies launching new products/services
Table 131 Key companies undergoing partnerships
Table 132 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value - chain - based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Immunofluorescence assay market: Product outlook and key takeaways
Fig. 16 Immunofluorescence assay market: Product movement analysis
Fig. 17 Global antibodies market, 2018 - 2030 (USD Million)
Fig. 18 Global kits and reagents market, 2018 - 2030 (USD Million)
Fig. 19 Global instruments market, 2018 - 2030 (USD Million)
Fig. 20 Global consumables and accessories market, 2018 - 2030 (USD Million)
Fig. 21 Immunofluorescence assay market: Type outlook and key takeaways
Fig. 22 Immunofluorescence assay market: Type movement analysis
Fig. 23 Global indirect immunofluorescence market, 2018 - 2030 (USD Million)
Fig. 24 Global direct immunofluorescence market, 2018 - 2030 (USD Million)
Fig. 25 Immunofluorescence assay market: Application outlook and key takeaways
Fig. 26 Immunofluorescence assay market: Application movement analysis
Fig. 27 Global cancer market, 2018 - 2030 (USD Million)
Fig. 28 Global infectious diseases market, 2018 - 2030 (USD Million)
Fig. 29 Global autoimmune diseases market, 2018 - 2030 (USD Million)
Fig. 30 Global other applications market, 2018 - 2030 (USD Million)
Fig. 31 Immunofluorescence assay market: End - user outlook and key takeaways
Fig. 32 Immunofluorescence assay market: End - user movement analysis
Fig. 33 Global academic research institutes market, 2018 - 2030 (USD Million)
Fig. 34 Global pharmaceutical & biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 35 Global CROs market, 2018 - 2030 (USD Million)
Fig. 36 Global hospitals and diagnostic centers market, 2018 - 2030 (USD Million)
Fig. 37 Immunofluorescence assay market: Regional outlook and key takeaways
Fig. 38 North America: SWOT Analysis
Fig. 39 North America immunofluorescence assay market, 2018 - 2030 (USD Million)
Fig. 40 U.S. key country dynamics
Fig. 41 U.S. immunofluorescence assay market, 2018 - 2030 (USD Million)
Fig. 42 Canada key country dynamics
Fig. 43 Canada immunofluorescence assay market, 2018 - 2030 (USD Million)
Fig. 44 Europe: SWOT Analysis
Fig. 45 Europe immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Germany key country dynamics
Fig. 47 Germany immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 France key country dynamics
Fig. 49 France immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 U.K. key country dynamics
Fig. 51 U.K. immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Italy key country dynamics
Fig. 53 Italy immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Spain key country dynamics
Fig. 55 Spain immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Denmark key country dynamics
Fig. 57 Denmark immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Sweden key country dynamics
Fig. 59 Sweden immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Norway key country dynamics
Fig. 61 Norway immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Rest of Europe key country dynamics
Fig. 63 Rest of Europe immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Asia - Pacific: SWOT Analysis
Fig. 65 Asia - Pacific immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 China key country dynamics
Fig. 67 China immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 India key country dynamics
Fig. 69 India immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea key country dynamics
Fig. 71 South Korea immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Japan key country dynamics
Fig. 73 Japan immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Australia key country dynamics
Fig. 75 Australia immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Thailand key country dynamics
Fig. 77 Thailand immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Latin America: SWOT Analysis
Fig. 79 Latin America immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Brazil key country dynamics
Fig. 81 Brazil immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Mexico key country dynamics
Fig. 83 Mexico immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Argentina key country dynamics
Fig. 85 Argentina immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 MEA: SWOT Analysis
Fig. 87 MEA immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait immunofluorescence assay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Heat map analysis
Fig. 97 Market participant categorization
Fig. 98 Immunofluorescence assay market share analysis, 2022
Fig. 99 Strategy framework

Companies Mentioned

  • thermo Fisher Scientific Inc.
  • Inova Diagnostics, Inc.
  • Bio - Rad Laboratories, Inc.
  • Abcam Plc
  • Perkinelmer Inc.
  • Merck Kgaa
  • Cell Signaling Technology, Inc.
  • Medipan Gmbh
  • Sino Biological, Inc.
  • Danaher Corporation

Methodology

Loading
LOADING...